CONSTANT LEVERAGE SHORT - PFIZER INC Stock

Certificat

NS6IB

NLBNPNL245Y7

Market Closed - Euronext Paris 12:30:01 2024-05-20 EDT
21.1 EUR -0.26% Intraday chart for CONSTANT LEVERAGE SHORT - PFIZER INC
Current month-34.93%
1 month-34.89%
Date Price Change
24-05-20 21.1 -0.26%
24-05-17 21.15 +2.22%
24-05-16 20.69 +1.05%
24-05-15 20.48 -7.42%
24-05-14 22.12 +0.71%

Real-time Euronext Paris

Last update May 20, 2024 at 12:30 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellPUT
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
NS6IB
ISINNLBNPNL245Y7
Date issued 2022-10-26
Maturity Unlimited
Parity 1 : 1
Emission price 10
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 34.98
Lowest since issue 5.115
Spread 0.13
Spread %0.61%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.53 USD
Average target price
31.94 USD
Spread / Average Target
+11.95%
Consensus
  1. Stock Market
  2. Certificates
  3. NS6IB Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW